ARROWHEAD PHARMACEUTICALS, INC. Quarterly Interest Expense in USD from Q1 2022 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Arrowhead Pharmaceuticals, Inc. quarterly/annual Interest Expense history and growth rate from Q1 2022 to Q1 2024.
  • Arrowhead Pharmaceuticals, Inc. Interest Expense for the quarter ending March 31, 2024 was $7.24M, a 43.2% increase year-over-year.
  • Arrowhead Pharmaceuticals, Inc. Interest Expense for the twelve months ending March 31, 2024 was $23M.
  • Arrowhead Pharmaceuticals, Inc. annual Interest Expense for 2023 was $18.3M.
  • Arrowhead Pharmaceuticals, Inc. annual Interest Expense for 2022 was $0.000.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $23M $7.24M +$2.19M +43.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $20.8M $5.37M +$2.52M +88.4% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-06
Q3 2023 $18.3M $5.26M Jul 1, 2023 Sep 30, 2023 10-K 2023-11-29
Q2 2023 $5.16M +$5.16M Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-07
Q1 2023 $5.06M +$5.06M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $2.85M Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-06
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $0 Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-02
* An asterisk sign (*) next to the value indicates that the value is likely invalid.